Broadfin Capital, LLC, 10% Owner at ARATANA THERAPEUTICS, INC. (PETX), sold 468,651 shares at $5.53 ($2.6M) on 2017-12-01, disclosed to the SEC on 2017-12-01.
Open-market sale of $2.6M PETX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.26 | 1,900 | $12K | 0.5% |
| 2 | $6.28 | 300 | $2K | 0.1% |
| 3 | $6.35 | 7,700 | $49K | 1.9% |
| 4 | $6.55 | 5,751 | $38K | 1.5% |
| 5 | $6.66 | 1,000 | $7K | 0.3% |
| 6 | $5.97 | 11,472 |
| $68K |
| 2.7% |
| 7 | $6.03 | 100 | $603 | 0.0% |
| 8 | $5.40 | 425,298 | $2.3M | 89.8% |
| 9 | $5.44 | 1,900 | $10K | 0.4% |
| 10 | $5.47 | 100 | $547 | 0.0% |
| 11 | $5.52 | 5,110 | $28K | 1.1% |
| 12 | $5.53 | 8,020 | $44K | 1.7% |
| Total | $5.45 avg | 468,651 | $2.6M | 100% |
| Filing → |
| BDSI | SELL | 2019-05-14 | $9.0M | — | Filing → |
| REPH | SELL | 2018-05-24 | $1.1M | — | Filing → |
| REPH | SELL | 2018-03-15 | $2.0M | — | Filing → |